Indrayani Biotech Limited announced the outcome of a meeting of its Rights Issue Committee held on May 25, 2026. The committee revised the schedule for the company's partly paid-up Rights Issue.
The key changes to the schedule are:
- The Rights Issue, originally scheduled to open on May 27, 2026 and close on June 25, 2026, will now open on June 25, 2026 and close on July 24, 2026.
- The last date for on-market renunciation has been revised from June 16, 2026 to July 20, 2026.
Revised issue documents including the Letter of Offer (LOF), Abridged Letter of Offer (ALOF), Composite Application Form (CAF), and Entitlement Letter will be made available on the websites of BSE Limited (www.bseindia.com) and the company (www.indrayani.com).
The disclosure explicitly states that except for the changes to the Issue opening date, Issue closing date, and the last date for on-market renunciation, there are no other changes in the issue documents.
The communication was signed by R Ramya, digitally signed as R RAMYA, who is identified as Ramya Ravi, Company Secretary and Compliance Officer for Indrayani Biotech Limited. The letter was addressed to the Listing Operations Department of BSE Limited.